Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.19.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Jul. 28, 2016
Unpaid balance $ 0   $ 0      
Proceeds from royalty     3,000,000      
Related party payables 196,642   196,642   $ 32,318  
Common stock shares issued during the period       12,500    
FFE [Member]            
Monthly remuneration 14,583   14,583      
Consulting fees 43,750 $ 40,798 87,500 $ 80,798    
Unpaid balance 0   $ 0   0  
Director [Member]            
Common stock shares issued during the period     12,086      
BioCorRx Pharmaceuticals, Inc [Member]            
Ownership percentage hold by former officers           24.20%
Ownership percentage hold by company           75.80%
Mr. Tom Welch, VP of Operations [Member]            
Monthly remuneration 12,500   $ 12,500      
Consulting fees 37,500   75,000      
Unpaid balance 0   0   0  
Soupface LLC [Member]            
Monthly remuneration 15,833   15,833      
Compensation for services     15,583      
Consulting fees 47,500 43,750 95,000 87,500    
Unpaid balance         0  
PARS [Member]            
Monthly remuneration 14,583   14,583      
Consulting fees 0 $ 0 0 $ 0    
Unpaid balance $ 0   $ 0   $ 32,318